Mobile

A multi-center, randomized, open-label, controlled, one-year trial to measure the effect of zoledronic acid and alendronate on bone metabolism in post menopausal women with osteopenia and osteoporosis

Update Il y a 4 ans
Reference: EUCTR2006-001703-11

Woman Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To prove superiority of zoledronic acid compared to alendronate by testing the hypothesis that the change of the level of NTx in serum within the first 12 months after start of therapy in postmenopausal women is higher.

Inclusion criteria

  • osteopenia/osteoporosis in postmenopausal women

Links